• Health & Medicine

Highly sensitive blood test could improve breast cancer treatment

A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests. A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests.

7 August 2019

• Science & Technology

Tumour liquefying microbubbles: UK’s first convergence science centre officially launches

Using ultrasound technology to liquefy cancer cells is just one of the projects at the new £13 million Cancer Research UK Convergence Science Centre. Using ultrasound technology to liquefy cancer cells is just one of the projects at the new £13 million Cancer Research UK Convergence Science Centre.

29 July 2019

• Health & Medicine

NHS to ‘fast track’ new personalised cancer medicines – but it’s not ready quite yet

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients. NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

19 June 2019

• Science & Technology

The scientists on a mission to revolutionise brain tumour research

Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research. Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research.

17 June 2019

• For Supporters

Glioblastoma and children’s brain tumours: teams awarded £18 million Cancer Research UK Brain Tumour Awards

Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop. Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.

17 June 2019

• Health & Medicine

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy. A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

2 June 2019

• Health & Medicine

Immunotherapy comparable to chemo for some advanced stomach cancers

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe. An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.

1 June 2019

• Health & Medicine

Precision drug combo boosts survival in younger women with advanced breast cancer

Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial. Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.

1 June 2019

• Science & Technology

Learning about advanced cancer from the people who donate their bodies after death

We look at the research made possible by people who donate their bodies after their death, including helping scientists understand how advanced cancers spread. We look at the research made possible by people who donate their bodies after their death, including helping scientists understand how advanced cancers spread.

28 May 2019

• Health & Medicine

Cancer Research UK to test targeted drug in pancreatic cancer

A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine. A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.

17 May 2019

• Health & Medicine
• Science & Technology

Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers

Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results. Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.

15 May 2019